Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Hypertension (Dallas, Tex. : 1979)|March 9, 2022
Impact of Antihypertensive Drug Class on Outcomes in SPRINTDouglas D DeCarolis, Amy Gravely, Christine M Olney, et al.
Intensive & Critical Care Nursing|February 13, 2016
Comparative dose response using the intravenous versus enteral route of administration for potassium replenishmentDouglas D DeCarolis, Grace Miran Kim, Thomas S Rector, et al.
The Annals of Pharmacotherapy|October 26, 2002
Comparison of plasma concentrations for two amiodarone productsShari C Sauro, Douglas D DeCarolis, Gordon L Pierpont, et al.
Pharmacotherapy|March 27, 2007
Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unitDouglas D DeCarolis, Kathryn L Rice, Libin Ho, et al.
Diagnostic Microbiology and Infectious Disease|November 26, 2008
Treatment of non-life-threatening methicillin-resistant Staphylococcus aureus infections with alternative antimicrobial agents: a 2-year retrospective reviewDimitri M Drekonja, Laura M Traynor, Douglas D DeCarolis, et al.
Therapeutic Drug Monitoring|September 16, 2014
Comparison of equations with estimate renal function to predict serum vancomycin concentration in patients with spinal cord injury--does the use of cystatin C improve accuracy?Douglas D DeCarolis, Joey G Thorson, Rebecca A Marraffa, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 17, 2019
Decreased warfarin sensitivity among patients treated with elbasvir and grazoprevir for hepatitis C infectionDouglas D DeCarolis, Yi-Chieh Chen, Anders D Westanmo, et al.
Archives of Internal Medicine|November 7, 2012
Enoxaparin outcomes in patients with moderate renal impairmentDouglas D DeCarolis, Joey G Thorson, Megan A Clairmont, et al.
The American Journal of Medicine|September 28, 2011
Antimicrobial use and risk for recurrent Clostridium difficile infectionDimitri M Drekonja, William H Amundson, Douglas D Decarolis, et al.
The Annals of Pharmacotherapy|July 29, 2016
Evaluation of a Potential Interaction Between New Regimens to Treat Hepatitis C and WarfarinDouglas D DeCarolis, Anders D Westanmo, Yi-Chie Chen, et al.
Pageof 2